developing bioanalytical methods · 1. potency assays are key in making medicines 2. bioassays...
TRANSCRIPT
![Page 1: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/1.jpg)
Developing Bioanalytical MethodsBalancing the Statistical Tightrope
![Page 2: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/2.jpg)
“Lee: can I use this number?”
Process Development
GSK, 1997
2
![Page 3: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/3.jpg)
“it’s about 40”
“about 40?”
“probably...”
3
![Page 4: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/4.jpg)
Enlightenment?
![Page 5: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/5.jpg)
5
![Page 6: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/6.jpg)
Unconscious
Conscious
Incompetent Competent
ConsciousnessBlooms Taxonomy
the 4 stages of competence
6
![Page 7: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/7.jpg)
Me
A Statistical God
![Page 8: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/8.jpg)
Using Statistics
![Page 9: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/9.jpg)
1. Potency assays are key in making medicines
2. Bioassays are very variable
3. Statistics will help you understand your data
4. Understanding your data will reveal if control exists
5. Your level of control allows you to judge RISK
6. Regulators globally require it
Why? Six Reasons
9
![Page 10: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/10.jpg)
The Regulator & Assay Control
1. Pharmaceutical cGMPs for the 21st
Century
2. PAT
3. ICH Q2: Validation of Analytical
Procedures
4. ICH Q8: Pharmaceutical Development
5. ICH Q9: Quality Risk Management
6. ICH Q10: Quality Pharmaceutical
Systems
Regulators have been asking for this for years! QbD
10
![Page 11: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/11.jpg)
Statistics
The complete solution?
![Page 12: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/12.jpg)
Or this?
Your assay?12
![Page 13: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/13.jpg)
Or this?
or your assay?
13
![Page 14: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/14.jpg)
Statistics - an Amazing Transition
14
![Page 15: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/15.jpg)
Bioassays will always be variable
You can improve it
- by understanding it
- Focusing effort in right places
- This brings control
- You can manage expectations
- This is understood by regulators
15
![Page 16: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/16.jpg)
Why assay variation matters?
product variation +
assay variation +
inaccuracy
Many satisfactory OOS batches likely to fail (potentially costing £Ms)
because of combination of assay method & process inaccuracy & variation
A few unsatisfactory
batches may even
pass specification
due to a combination
of assay method and
process variability
16
![Page 17: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/17.jpg)
Our Control Strategy
What does the scientist need to achieve?
i.e. selectivity, accuracy, precision linearity
Measure
Analyse
Improve
Control
Define
Identify & prioritise analytical CNX parameters
eXperimental
parameters
e.g., DoE
Regression
Noise
parameters
e.g., MSA,
Precision
Control
parameters
Fix & control
Method
Robustness
Method
Ruggedness
Method Control Strategy & reduce Risk prior to
Validation → Routine Use & Continuous Improvement
Input into
17
![Page 18: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/18.jpg)
Generating Bioassay
Data
18
![Page 19: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/19.jpg)
1. Speak with your statistician before
generating data
2.See Rule 1
The Rules
19
![Page 20: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/20.jpg)
Lot’s data ≠ Value
20
![Page 21: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/21.jpg)
21
![Page 22: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/22.jpg)
Statistics are a tool 22
![Page 23: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/23.jpg)
Which Tools?
Design
QC
Precision
Accuracy
Linearity etc.
TIME
UCL
LCL
Stage 1:
Qualification Tool
Fishbone, Minitab
Stage 2:
Development ToolsDX8, JMP, Minitab
Stage 3:
Validation ToolsNested, CELLULA
Stage 4
QC ToolsCELLULA, Shewhart chart,
CUSUM
Technology
TransferYES
NO
![Page 24: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/24.jpg)
What’s Appropriate Knowledge?
• Learning takes time
• Will you use it often enough?
• It’s not an academic pursuit
• Activities must add value
do what’s necessary
24
![Page 25: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/25.jpg)
Scope
&
Design
![Page 26: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/26.jpg)
26
Define & Scope
How is the assay performing? Prec/TOL2-sided = 6 x 16.76
100
= 1.01
![Page 27: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/27.jpg)
Parameters (e.g. 15)pDNA
NaCl
pH
Tube Length
Time
Seeding Density
Ratio of Transfection
Temperature
Agitation and level
Vector – type, conc
Addition Order
![Page 28: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/28.jpg)
Q. How Many parameters?
Q. Which parameters?
Q. What ranges?
A. Existing knowledge
A. Common sense
A. Practical limits
![Page 29: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/29.jpg)
29
Define & Scope
Drill down - map out assay - build understanding & scope
Assay Flow
![Page 30: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/30.jpg)
30
Define & Scope
Drill down & map out assay to build understanding & scope
Attention is focused
toward key steps
and the parameters
involved in these
steps
Cause & Effect Diagram (Fishbone) helps think your assay through
Identify & prioritise analytical CNX parameters
![Page 31: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/31.jpg)
Scope & Screen
31
Scope ranges with simple experiments
Scoping Experiments
Explore mildest
to most forcing
conditions
![Page 32: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/32.jpg)
32
Revealing the Big Hitters
![Page 33: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/33.jpg)
Temptation
![Page 34: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/34.jpg)
34
OFAT
pH
pDNA
NaCl
Provides estimates
of effects at set
conditions of the
other factors and
no interaction
effects.
Building Understanding
![Page 35: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/35.jpg)
35
Building Understanding
Factorial Design
Estimates effects at
different conditions to
estimate interactions
Design of Experiments
DOE
250
1300900
300 500
1800
350 600
2400 2600
![Page 36: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/36.jpg)
36
work towards a
Robust Optimum
Optimise the parameters that
survived the initial screening
Optimisation
![Page 37: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/37.jpg)
37
The tools allow you to simulate scenarios using the data you’ve built up
Simulations
Visual simulation of expected performance relative to specification
![Page 38: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/38.jpg)
Is the Model Correct?
38
![Page 39: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/39.jpg)
39
Ideal Settings
Control Space
Design Space
Method stretch…what if?
The evaluation of robustness should be considered during the development phase and should show the reliability of an analysis with respect to deliberate variations in method parameters ICH Q2B, 1994
Validate & Verify
![Page 40: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/40.jpg)
Assay Control: control the parameters inside boundaries
40
![Page 41: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/41.jpg)
Even if you go outside
the control boundaries,
the assay will have
enough flexibility to deal
with it without an OOS
41
Working within the control
boundaries will keep the assay
under control
![Page 42: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/42.jpg)
Summary - Data Driven Development
Scope
Explore mildest
to most forcing
conditions
Optimize
Estimate & utilize
interactions to move
towards optimum
conditions
Verify
Rattle the cage to
deliver a design
space
QC/TT
Transfer to QC to
validate on batches
& bring into routine
use
Identify few potential
key parameters
Focus on vital few &
narrow ranges
Screen
![Page 43: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/43.jpg)
43
![Page 44: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/44.jpg)
Precision
It may be considered at three levels:
1. Repeatability
2. Intermediate precision
3. Reproducibility
ICH Q2A, 1994
![Page 45: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/45.jpg)
Repeatability
1 analyst in 1 laboratory on 1 day injecting 6 times
Summary Statistics
Number of
Values Mean
Standard
Deviation
Coefficient
of Variation
Lower 95% CI
for Mean
Upper 95%
CI for Mean
t30 PS 6 223.27 6.43 2.88% 216.52 230.02
45
![Page 46: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/46.jpg)
Intermediate Precision
As well as sample variation, this study still provides information on repeatability
46
• 1 analyst in 1 laboratory on
• 1 day
• injecting 6 samples
• each tested 6 times
![Page 47: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/47.jpg)
So we compare the mean values for each sample (over replicate results per sample)
Intermediate Precision
Variance Components
Factor df Variance % Total
Sample 5 27.8535 21%
Repeat 30 102.6361 79%
35 130.4896 100%
Standard
Mean Deviation RSD
216.24 11.4232 5.28%47
![Page 48: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/48.jpg)
and the others…..?
Precision within a laboratory but with different analysts, on different days, with different equipment…reflects the real conditions within one laboratory
ICH Q2A 1995
48
![Page 49: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/49.jpg)
49
Y
52000
52500
53000
53500
54000
54500
55000
55500
56000
0 5 10 15 20 25
Sample
Pe
ak
Are
a
Data collect using several analysts using several instruments
over several days:
Intermediate Precision
![Page 50: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/50.jpg)
50
Y
52000
52500
53000
53500
54000
54500
55000
55500
56000
0 5 10 15 20 25
Sample
Pe
ak
Are
a
Potentially misleading: large analyst-to-analyst variation
present:
Analyst 1 Analyst 2 Analyst 3
Intermediate Precision
![Page 51: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/51.jpg)
51
better examined looking at multiple sources of variation within an assay
Intermediate Precision
want to understand
major sources of
variation such as
sample, prep,
analyst etc.
![Page 52: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/52.jpg)
52
Intermediate Precision
![Page 53: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/53.jpg)
Can also perform Unbalanced designs
Intermediate Precision
One operator performs multiple injections on single
preparation;
Two operators perform single injections on multiple
preparations
53
![Page 54: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/54.jpg)
54
…. sent to and analysed by other lab
C
B
A
CBA
Samples from
laboratory:
multiple laboratories; typically run as an inter-laboratory cross-over study, with each participating lab sending samples to every other lab and analysing all samples (including own)
Reproducibility
![Page 55: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/55.jpg)
Can use analysis of variance (ANOVA) to look for differences or biases between labs
Alternatively look for “analytical equivalence”
Reproducibility
![Page 56: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/56.jpg)
Risk ManagementThe level of effort, formality and documentation.. ..should be commensurate with the level of risk
ICH Q9
Evaluation of the risk to quality should be based on scientific knowledge & ultimately link to the protection of the patient
Is the bioassay fit for purpose and under control?
56
![Page 57: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/57.jpg)
57
Before & After
How is the assay performing? P/TOL2-sided = 6 x 16.76
100
= 1.01
![Page 58: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/58.jpg)
58
Better P/TOL2-sided = 6 x 6.99
100
= 0.42
Before & After
![Page 59: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/59.jpg)
59
Risk ManagementMethod Understanding, Control and Capability (MUCC)
Understand impact of variation
upon risk…
Capability
& Precision
Capable?
Control?
Risk
Management
Loop
Understanding?
Statistical
Process Control
(SPC) Charts
![Page 60: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/60.jpg)
60
Understanding?
Capability
& Precision
Capable?Understanding?
100
= 1.01
P/TOL2-sided = 6 x 16.76
Capable? Control?
Risk Management
![Page 61: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/61.jpg)
61
> 5% 0%
NoYes
0.0%
on the I chart.
The process mean is stable. No data points are out of control464136312621161161
225
210
195
180
Observation
t30
PS
_X=199.87
UCL=220.77
LCL=178.96
464136312621161161
30
20
10
0
Observation
Mo
vin
g R
an
ge
__MR=7.86
UCL=25.68
LCL=0
Comments
I-MR Chart of t30 PS
Summary Report
Is the process mean stable?
Evaluate the % of out-of-control points.I Chart
Investigate out-of-control points.
MR Chart
Investigate out-of-control points.
P/TOL2-sided = 6 x 6.99
100
= 0.42
Risk Management
![Page 62: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/62.jpg)
1.Build a good basic understanding of
stats but don’t need to become guru
2.Involve a statistician, at least at the
beginning
3.Build understanding of your bioassay
(QbD) – it’s a must
4.Get to grips with Bioassay Variability
Summary
62
![Page 63: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/63.jpg)
“Lee: can I use this number?”
63
![Page 64: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/64.jpg)
“Yes – it’s 42 ”
0.05 with 95% Confidence
for the statisticians in the audience
64
…
![Page 65: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/65.jpg)
Acknowledgments
Dr. Paul Nelson – Prism TC Ltd
Pictures from “The Cartoon Guide to Statistics” Larry Gonick & Woollcott Smith
65
![Page 66: Developing Bioanalytical Methods · 1. Potency assays are key in making medicines 2. Bioassays arevery variable 3. Statistics will help you understand your data 4. Understanding your](https://reader033.vdocuments.site/reader033/viewer/2022053105/606f7361f8ce72641b6a56a4/html5/thumbnails/66.jpg)